Cargando…

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis

Detalles Bibliográficos
Autores principales:	Fuggle, Nicholas, Al-Daghri, Nasser, Bock, Olivier, Branco, Jaime, Bruyère, Olivier, Casado, Enrique, Cavalier, Etienne, Cortet, Bernard, de Wit, Maarten, Giusti, Andrea, Halbout, Philippe, Harvey, Nicholas C., Hiligsmann, Mickaël, Kaufman, Jean-Marc, Kurth, Andreas, Maggi, Stefania, Matijevic, Radmila, Minisola, Salvatore, Palacios, Santiago, Radermecker, Régis Pierre, Thomasius, Friederike, Tuzun, Sansin, Veronese, Nicola, Kanis, John A., Reginster, Jean-Yves, Rizzoli, René, Cooper, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200775/ https://www.ncbi.nlm.nih.gov/pubmed/36595210 http://dx.doi.org/10.1007/s40520-022-02319-1

Ejemplares similares

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Management of patients at very high risk of osteoporotic fractures through sequential treatments
por: Curtis, Elizabeth M., et al.
Publicado: (2022)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
por: Veronese, Nicola, et al.
Publicado: (2022)

Vitamin D and osteosarcopenia: an update from epidemiological studies
por: Bruyère, Olivier, et al.
Publicado: (2017)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Alternative and complementary therapies in osteoarthritis and cartilage repair
por: Fuggle, N. R., et al.
Publicado: (2020)

Effects of vitamin D in the elderly population: current status and perspectives
por: Bruyère, Olivier, et al.
Publicado: (2014)

Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies
por: Veronese, Nicola, et al.
Publicado: (2022)

Comment on: The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large US Claims Database
por: Pegreffi, Francesco, et al.
Publicado: (2023)

Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
por: Shevroja, Enisa, et al.
Publicado: (2023)

Sarcopenia: burden and challenges for public health
por: Beaudart, Charlotte, et al.
Publicado: (2014)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
por: Kanis, J. A., et al.
Publicado: (2017)

Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
por: Honvo, Germain, et al.
Publicado: (2019)

The interconnection between Covid-19, sarcopenia and lifestyle
por: Demonceau, Céline, et al.
Publicado: (2023)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study
por: Sanchez‐Rodriguez, Dolores, et al.
Publicado: (2020)

Measures of attributes of locomotor capacity in older people: a systematic literature review following the COSMIN methodology
por: Honvo, Germain, et al.
Publicado: (2023)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
por: Bruyère, Olivier, et al.
Publicado: (2008)

An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis
por: Tenti, Sara, et al.
Publicado: (2023)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

Neurofilament light chain concentration in an aging population
por: Ladang, Aurélie, et al.
Publicado: (2022)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
por: Ladang, Aurélie, et al.
Publicado: (2023)

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
por: Ladang, Aurélie, et al.
Publicado: (2023)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Attributes and definitions of locomotor capacity in older people: a World Health Organisation (WHO) locomotor capacity working group meeting report
por: Veronese, Nicola, et al.
Publicado: (2022)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study
por: Tenti, Sara, et al.
Publicado: (2022)

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: de Wit, Maarten, et al.
Publicado: (2019)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ut2bm0jtd0369c1g20s6tivs34